A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Clinical trial NCT07321886 · RECRUITING

Trial details

NCT number: NCT07321886
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Overweight

Start date: 2026-02-06
Primary completion: 2028-03-01
Enrollment: 1980

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.